Outlook Therapeutics Cash from Other Financing Activities (Quarterly) Analysis

Outlook Therapeutics, Inc. (OTLK)

0.40 -0.01 (-3.17%) USD | NASDAQ | Feb 23, 16:00

0.402 0.00 (0.00%) After-Hours: 19:59

View Cash from Other Financing Activities (Quarterly) for OTLK.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Cash from Other Financing Activities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Cash from Other Financing Activities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Cash from Other Financing Activities (Quarterly) Benchmarks

Start Trial

Ironwood Pharmaceuticals, Inc.	--
Amicus Therapeutics, Inc.	Upgrade
Neogen Corp.	Upgrade
CorMedix, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	--